Apple and Samsung have been exploring ways to provide non-invasive blood glucose readings through their smartwatches for a while now. This innovation could greatly benefit insulin-dependent diabetics by simplifying the process of determining insulin dosage before meals. Currently, diabetics must endure a painful and costly process involving lancets, test strips, and glucometers to monitor their blood glucose levels.

Fortunately, there is an alternative solution available that does not require a prescription. The FDA has recently cleared the Dexcom Stelo Glucose Biosensor System for over-the-counter use. This continuous glucose monitor (CGM) offers a hassle-free way to monitor blood sugar levels without the need for invasive procedures.

The Dexcom Stelo Glucose Biosensor System utilizes a wearable sensor that communicates with a smartphone or other smart device via Bluetooth, providing real-time readings every 15 minutes. It is designed for individuals aged 18 and above who do not use insulin, such as those managing diabetes with oral medications or individuals without diabetes seeking to understand how diet and exercise impact their blood sugar levels.

Key points about the Dexcom Stelo Glucose Biosensor System:
– Monitors blood glucose levels every 15 minutes
– Wearable sensor with Bluetooth connectivity to smartphones
– Intended for individuals not using insulin
– Each sensor can be worn for up to 15 days before replacement

While Apple and Samsung continue their efforts towards integrating non-invasive blood glucose monitoring into their smartwatches, it is essential to note that current technologies may not be as reliable. The FDA advises against relying on non-invasive monitors at this time due to accuracy concerns. The Dexcom Stelo Glucose Biosensor System is set to launch this summer, offering a promising option for individuals looking for convenient and accurate blood glucose monitoring solutions.